Crossmark

Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD-PRO

Crossref DOI link: https://doi.org/10.1007/s12350-017-1035-4

Published Print: 2018-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Di Carli, Marcelo F.
License Information

Text and Data Mining valid from 2018-02-01

Text and Data Mining valid from 2018-02-01
More Information

This article is maintained by: Elsevier

Article Title: Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD-PRO

Journal Title: Journal of Nuclear Cardiology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s12350-017-1035-4

Content Type: article

Copyright: Copyright © 2018 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.

Document is current

Any future updates will be listed below